Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1395775 | European Journal of Medicinal Chemistry | 2006 | 4 Pages |
Abstract
Herein, we describe a new strategy for the preparation of thiazolothiazepine-based inhibitors of human immunodeficiency virus type-1 integrase (IN). The present method allows facile preparation of the title compounds in a single enantiomeric form starting from l-4-thiazolidinecarboxylic acid. This method could be easily extended to the synthesis of several analogs derived from optically active cyclic aminoacids. We also present a putative model showing the interaction between l- and d-isomers of compound 1 in the IN active site. A sensibly lower IC50 value was found for (–)-1 over racemic-1 in an anti-IN assay.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide
Keywords
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
F. Aiello, A. Brizzi, O. De Grazia, A. Garofalo, F. Grande, M.S. Sinicropi, R. Dayam, N. Neamati,